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Abstract
Background: Dopamine is involved in several cerebral physiological processes, and single nucleotide polymorphisms
(SNP) in the dopamine D2 receptor gene (DRD2) have been associated with numerous neurological and mental
disorders, including those involving alterations in cognitive and emotional processes.
Methods: The aim of this study was to evaluate the association between the SNPs c.957C > T (rs6277) and c.-585A > G
(rs1799978) in the DRD2 gene and behavioral characteristics of children and adolescents based on an inventory of the
Child Behavior Checklist (CBCL). Children and adolescents between 8 and 20 years old who were clinically followed-up
were genotyped for the SNPs c.957C > T and c.-585A > G, and related to data of the CBCL/6–18 scale assessment
performed with the help of caregivers. The chi-squared test was used to assess the differences in the frequencies of
the C and T alleles in the polymorphism c.957C > T and of the A and G alleles in the polymorphism c.-585A > G with
respect to the grouped CBCL scores at a significance level of 5%. Multiple logistic regression models were performed,
to control whether sex and/or ethnicity could influence the results.
Results: Eighty-five patients were assessed overall, and the presence of the T allele (C/T and T/T) of DRD2 c.957C > T
polymorphism was found to be significantly associated with the occurrence of defiant and oppositional problems and
with attention and hyperactivity problems. There were no associations detected with polymorphism DRD2 c.-585A > G
polymorphism. Both SNPs were in Hardy-Weinberg-equilibrium.
Conclusions: Although the findings of this study are preliminary, due to its small number of participants, the presence
of T allele (C/T, T/T) in c.957C > T SNP was associated with difficulty in impulse control, self-control of emotions, and
conduct adjustment, which can contribute to improving the identification of mental and behavioral phenotypes
associated with gene expression.
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Background
The dopamine D2 receptor gene (DRD2), located at
chromosome 11q23.1, is involved in several cerebral
physiological processes, including behavior inhibition
and externalizing conditions, i.e., aggression and symp-
toms such as oppositional defiance, conduct problems,
and attention deficit/hyperactivity [1–7].
The single nucleotide polymorphism (SNP) c.957C > T
(rs6277) is located on the seventh exon of DRD2 gene at
the 319 codon that codes a proline [8]. Individuals with
C/C homozygous genotypes, associated with a higher
density of extrastriatal D2 receptors, were shown to be
more efficient in inhibiting unwanted action tendencies
and showed increased reward responsiveness after stress
induction compared to T/− carriers [5, 9]. The presence
of the T allele is associated with a reduction of the trans-
lation and stability of the messenger RNA (mRNA), and
with a reduction in protein synthesis by up to 50% in
comparison with activity of the C allele [10–12].
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The functional consequence of SNP c.-585A > G
(rs1799978) is currently unknown; however, it is sus-
pected to regulate the expression of the DRD2 gene due
to its location on the promoter region [13]. The G allele
has been associated with conditions related to impulsive-
ness [14].
In this study, we tested the hypothesis that the T allele
of the c.957C > T (rs6277) polymorphism and/or the G
allele of the c.-585A > G (rs1799978) polymorphism are
associated with the occurrence of externalizing behaviors
among children and adolescents under psychiatric
treatment.
Methods
This was a descriptive cross-sectional study, with a sam-
ple composed of patients attending the Psychiatric Out-
patient Clinic of Children and Adolescents, Department
of Medical Psychology and Psychiatry, Clinical Hospital
and School of Medical Sciences, University of Campinas
(Unicamp) from March 2014 to August 2015. The center
provides a service that typically cares for severe cases,
most of whom are under a regime of psychotropic drugs,
requiring a more complex level of mental health atten-
tion than those receiving primary health care.
In addition to information about the use of medications
and diagnoses registered on medical records, the inven-
tory of the Child Behavior Checklist for the age range of
6–18 years old (CBCL/6–18) was used for qualification of
the presence and severity of the mental and behavioral
symptoms [15]. The CBCL/6–18 is a standardized ques-
tionnaire designed by Achenbach in 1991, answered by
the parents or caregivers, which is used to assess the be-
haviors of children or adolescents [16] and was validated
for application in the Brazilian population [17]. The
CBCL/6–18 is widely recommended as one of the most
effective tools for the qualification of parental responses
related to childhood behavior [18]. Such an inventory pro-
vides a profile of behavioral and emotional problems in
syndromic groups, but has not been validated as a diag-
nostic instrument [18, 19]. As the CBCL/6–18 does not
evaluate neurocognitive problems, individuals with severe
or profound intellectual disability were not included in
this study, because their behavioral symptoms would not
be differentiable between those associated with intellectual
disability itself and those due to other disruptive behav-
ioral disorders. The emotional/behavior problem section
of the CBCL/6–18 has 118 items [20]. The adult respond-
ent has to attribute the following scores to each problem:
0, not true; 1, somewhat true or rare; and 2, very true or
very frequent over the last six months [17]. Analysis of the
CBCL/6–18 scores was conducted with the software of
the Achenbach System of Empirically Based Assessment
[17], and the results were grouped into three kinds of pro-
files: syndrome-based scores, which evaluate symptoms
for each of the main clusters of mental health problems;
scales that mainly group psychological symptoms accord-
ing to internalizing and externalizing dimensions; and
scales consistent with DSM-IV scales [19]. The following
DSM-oriented scales were used: “anxiety problems”, “som-
atic problems”, “attention deficit hyperactivity disorder
problems”, “opposition and challenging problems”, and
“conduct problems” [19].
The results obtained from the CBCL/6–18 responses
from parents or other adult caregivers, and not the chil-
dren/adolescents, were used to classify the children/ado-
lescents into the following categories: “normal” (behavior
scores < 67, total scores < 60), “borderline clinical range”
(behavior scores 67–70, total scores 60–63), and “clinical
range” (behavior scores > 70, total scores > 63) [19].
The genomic DNA samples were obtained from 8 mL
of total peripheral blood collected in tubes with EDTA
(0.6 M), pH 8.0 as anticoagulant. Genomic DNA was
purified from peripheral leukocytes according to stand-
ard protocols by lysing with proteinase K, extracting
with phenol/chloroform, and precipitating with ethanol
[21]. To determine genotypes for c.957C > T (rs6277)
and c.-585A > G (rs1799978) in the DRD2 gene, real-
time PCR using TaqMan® allelic discrimination assay
(Applied Biosystems, Foster City, CA - USA) and primers
available from SNP Genotyping Assay (Applied Biosys-
tems, Foster City, CA - USA) were used. The total volume
for all reactions was 7 μl containing TaqMan Genotyping
PCR Master Mix 2X (3.5 μl) and SNP Genotyping Assay
40X (0.175 μl), MiliQ water (2.325 μl) and 10 ng of each
genomic DNA (1 μl). Reactions were performed in 96-well
optical plates (0.1 ml MicroAmp, Applied Biosystems) and
submitted to the following temperatures and cycles: a first
cycle of 10 min denaturation at 95 °C followed by 40 cycles
of 15 s at 95 °C and 1 min extension at 60 °C. Amplifica-
tion reactions were performed in a 7500 Fast Real-Time
PCR System (Applied Biosystems). Validation studies dem-
onstrate that the Applied Biosystems 7500 System SDS is
a robust, reliable, and reproducible system for performing
DNA quantification [22]. Data were recorded and ana-
lyzed using 7500 System Sequence Detection Software©
(SDS).Descriptive and chi-square statistical analyses were
carried out using SPSS version 22 (IMB Co., Armonk, NY,
USA). For relevant associations, multiple logistic regres-
sion analyses were carried out using Stata/SE version 14.1
(StataCorp LP, College Station, TX, USA). They were per-
formed to control whether the associations were due to
sex or ethnicity differences. Each model of multiple logis-
tic regression analysis used, as dependent variable, the
emotional/behavioral problem evaluated by CBCL 6/18
which had significant statistical association with the pres-
ence/absence of the T allele of the rs6277 SNP of the
DRD2 gene. Sex, ethnicity and the presence/absence of
the T allele itself were the independent variables.
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Hardy-Weinberg equilibrium was evaluated by the Hap-
loview software (BROAD Institute) [23, 24] to determine
if the allele frequencies of the SNPs assessed in the study
population were balanced and therefore applicable for
association studies. For the statistical analysis, the CBCL/
6–18 results were grouped into two distinct groups of two
categories each: in the first group, the results were com-
pared between those without alterations (“normal”) versus
those with alterations (“borderline clinical range” plus
“clinical range”); in the second group, the results were
compared between those without alterations or with few
alterations (“normal” plus “borderline clinical range”) ver-
sus those with substantial alterations (“clinical range”).
The chi-squared test was applied to evaluate the differ-
ences in the C and T allele frequencies for the polymorph-
ism c.957C > T and in the A and G allele frequencies for
the polymorphism c.-585A >G in relation to the grouped
scores of the CBCL/6–18. The significance level adopted
was 5%.
Results
This study comprised 85 patients with a mean age of
13.4 ± 2.7 years. Sixty-five patients (76.5%) were male.
The sample was composed of 61 (71.8%) Caucasian indi-
viduals, 15 (17.6%) bi-racial (African and Caucasian indi-
viduals), 8 (9.4%) African individuals, and 1 (1.2%) Asian
individual. The majority of the CBCL/6–18 assessment re-
spondents were women (84.7%), 54 (75%) of which were
the biological mothers. The other respondents included
fathers, grandparents, and shelter caregivers that accom-
panied the child or adolescent. Three participants had
already been hospitalized in a psychiatric inpatient ward,
due to severe disruptive behavior (one with 11 days of
hospitalization, one with 14 days and the third with
17 days), but all of them had already been discharged by
the time of the beginning of the study.
All patients were receiving risperidone therapy, and 19
patients (22.7%) were on risperidone monotherapy. By
the time of data collection, all participants were in psy-
chiatric outpatient treatment for externalized psycho-
pathological conditions in which risperidone may be
utilized. Antidepressants were also involved in the treat-
ment regimen of 46 (54.1%) cases, followed by psychosti-
mulants in 23 patients (27.1%) and clonidine in 11 patients
(12.9%). Anticonvulsants, lithium, benzodiazepines, and
other associated antipsychotics accounted for 17.6% (15 pa-
tients) of the total use of medicines. The medication had
been given for a mean of 34.6 ± 23.5 months.
According to the clinical evaluation made by experi-
enced psychiatrists and collected from the patients’ med-
ical records, the psychiatric syndromes were described
as: disruptive/aggressive (42 patients, 49.4%), hyperkinetic
(35 patients, 41.2%), depressive (29, 34.1%), intellectual
disability (24, 28.2%), autism (20, 23.5%), phobic-anxious
(17, 20%), learning disturbances (13, 15.3%), and psychotic
(6, 7.1%).
The DRD2 polymorphisms were in Hardy-Weinberg
equilibrium [c.957C > T (rs6277) p = 0.4169, c.-585A > G
(rs1799978) p = 0.246]. Table 1 shows the genotypic dis-
tribution, sample allele frequencies, and minor allele fre-
quencies (MAFs) of the SNPs for the study sample and
the global population according to the 1000 Genomes
Project and HapMap databases. The MAFs of the study
population were highly similar to those of the global
population for both polymorphic alleles.
Table 2 shows the genotypic distribution of the evalu-
ated SNPs of the DRD2 gene, regarding sex, age, psychi-
atric diagnoses and use of psychopharmacological
medications. No statistically significant associations were
found (p > 0.05). Regarding the CBCL/6–18 results, the
only significant associations between them and the poly-
morphisms were between the c.957C > T (rs6277) poly-
morphism and the occurrence of oppositional defiant
disorders, attention problems, and hyperactivity, which
are summarized in detail in Table 3. Figures 1 and 2
show the genotypic distribution of the rs6277 SNP (C/C,
C/T and T/T) regarding the CBCL/6–18 significant re-
sults. There were no significant associations for the SNP
c.-585A > G (rs1799978).
For challenging and oppositional problems according
to DSM-IV, multiple logistic regression models were per-
formed, to test whether the association of the presence
of the T allele of the rs6277 SNP of the DRD2 gene with
both oppositional problems and attention problems/
hyperactivity could be due to sex or ethnicity differences
between groups (Table 4). The presence or absence of
the T allele, regarding sex and ethnicity, is shown in
Table 4. Sex and ethnicity had no statistical associations
with any of the groups of symptoms studied (Table 4)
and, after the multiple logistic regressions, the presence
Table 1 Genotypic distribution and allele frequencies of DRD2 gene polymorphisms
SNP Genotype Allele frequency MAFa of the
study population
MAFa from the global database
rs6277 C/C 43 (50.6%)
C/T 37 (43.5%)
T/T 5 (5.9%)
C = 123 (72.35%)
T = 47 (27.65%)
T = 27.65% T = 24.4%
rs1799978 A/A 66 (77.6%)
A/G 19 (22.4%)
A = 151 (88.82%)
G = 19 (11.18%)
G = 11.18% G = 11.9%
aMAF minor allele frequency
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of the T allele remained associated both with challenging
and oppositional problems (odds ratio = 2.78 [CI95% = 1.
15–6.71]; p = 0.023) and, with less statistical significance,
with attention problems and hyperactivity (odds ratio =
2.69 [CI95% = 1.001–7.24]; p = 0.050) (Table 4).
Discussion
In the present study, the possible associations of the
polymorphisms c.957C > T (rs6277) and c.-585A >G
(rs1799978) of the DRD2 gene with the emotional/behav-
ior problem section of the CBCL/6–18 were investigated;
a significant association was detected between the poly-
morphism c.957C > T (rs6277) and the occurrence of op-
positional defiant disorders, attention problems, and
hyperactivity. The association remained after controlling
for sex and ethnicity.
The allele frequency of the SNP c.957C > T (rs6277)
was similar to that of the general population [25, 26]. It
Table 2 Genotypic distribution of the evaluated SNPs of the DRD2 gene, regarding demographic data, psychiatric diagnoses and
use of psychopharmacological medications
rs6277 rs1799978a
C/C C/T T/T A/A A/G
Sex
Female 13 (65%) 6 (30%) 1 (5%) 15 (75%) 5 (25%)
Male 30 (46.2%) 31 (47.7%) 4 (6.2%) 51 (78.5%) 14 (21.5%)
Age
8–10 years-old 6 (37.5%) 8 (50%) 2 (12.5%) 12 (75%) 4 (25%)
11–15 years-old 24 (48%) 23 (46%) 3 (6%) 39 (78%) 11 (22%)
More than 15 years-old 13 (68.4%) 6 (31.6%) 0 15 (78.9%) 4 (21.1%)
Intelligence quotient (IQ)
Normal 33 (52.4%) 27 (42.9%) 3 (4.8%) 49 (77.8%) 14 (22.2%)
Mild-Moderate intellectual disability 10 (45.5%) 10 (45.5%) 2 (9.1%) 17 (77.3%) 5 (22.7%)
Psychiatric condition
Disruptive/aggressive 20 (47.6%) 19 (45.2%) 3 (7.1%) 34 (81%) 8 (19%)
Hyperkinetic 16 (45.7%) 16 (45.7%) 3 (8.6%) 24 (68.6%) 11 (31.4%)
Depressive 15 (51.7%) 12 (41.4%) 2 (6.9%) 24 (82.8%) 5 (17.2%)
Autism 14 (70%) 5 (25%) 1 (5%) 16 (80%) 4 (20%)
Phobic-anxious 10 (58.8%) 6 (35.3%) 1 (5.9%) 13 (76.5%) 4 (23.5%)
Learning disturbances 5 (38.5%) 7 (53.8%) 1 (7.7%) 7 (53.8%) 6 (46.2%)
Psychotic 2 (33.3%) 4 (66.7%) 0 5 (83.3%) 1 (16.7%)
Psychiatric medication
Antipsychotics 43 (50.6%) 37 (43.5%) 5 (5.9%) 66 (77.6%) 19 (22.4%)
Antidepressants 26 (56.5%) 17 (37%) 3 (6.5%) 38 (82.6%) 8 (17.4%)
Psychostimulants 8 (34.8%) 12 (52.2%) 3 (13%) 18 (78.3%) 5 (21.7%)
Clonidine 5 (45.5%) 6 (54.5%) 0 10 (90.9%) 1 (9.1%)
Others 6 (40%) 7 (46.7%) 2 (13.3%) 11 (73.3%) 4 (26.7%)
aThere were no individuals with the G/G genotype of the rs1799978 SNP of the DRD2 gene
Table 3 Significant associations between the results of the CBCL/6-18 and the rs6277 polymorphism of the DRD2 gene
Presence of the T allele (C/T e T/T)* Absence of the T allele (C/C) p-value χ2
Challenging and oppositional problems according to the DSM-IV
No alteration (0) 14 (35.9%) 25 (64.1%) 0.022 5.265
With alteration (1 and 2) 28 (60.9%) 18 (39.1%)
Attention problems and hyperactivity by the DSM-IV
Few alterations (0 and 1) 26 (42.6%) 35 (57.4%) 0.046 3.983
Substantial alteration (2) 16 (66,7%) 8 (33,3%)
*There were no associations between the rs1799978 polymorphism of DRD2 and any of the CBCL/6-18 results
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is interesting to note that the genotype distributions of
the African, Asian, and European populations differ
from each other as well as from the population of the
present study; in particular, in the Asian and African
populations, the T/T genotype is extremely rare (6%)
and there is a higher frequency of heterozygotes in the
European population (54%), indicating heterogeneity
among these populations, and similarity between the Bra-
zilian and Amerindian populations [25, 26]. The allelic fre-
quency of the SNP c.-585A >G (rs1799978) in the study
population was similar to that of the general population,
with a slightly higher MAF of the G allele in the global
population (11.9% vs. 11.2%) [26, 27].
Ethnicity did not have statistical influence in the logistic
regression models. Moreover, Pena et al. in 2011 showed
that the race of individuals in Brazil cannot be predicted
from their genomic ancestry alone [28]. Understanding
the heterogeneity and admixture of Brazilians within and
between geographical regions has important clinical impli-
cations for the design and interpretation of clinical trials,
practice of clinical genetics and genomic medicine, imple-
mentation of pharmacogenetic knowledge in drug pre-
scriptions, and extrapolation of data from other, more
homogeneous populations [28]. The admixture propor-
tions vary greatly among Brazilian populations as well as
across Latin America [29]. The pooled ancestry contribu-
tions in Brazil are reported to be 0.62 European, 0.21 Afri-
can, and 0.17 Amerindian [29].
The results of the present study showed a higher fre-
quency association amongst externalizing symptoms,
which, according to Goodman, result in hyperactive, chal-
lenging, aggressive, or antisocial behaviors [30]. These
Fig. 1 Genotypic distribution of the c.957C>T (rs6277) SNP, regarding challenging and oppositional problems. Above: with alteration; Below:
no alteration
Fig. 2 Genotypic distribution of the c.957C>T (rs6277) SNP, regarding attention problems and hyperactivity. Above: substantial; Below: few
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symptoms include conditions of difficulties in impulse con-
trol, emotion self-control, and behavior regulation [30, 31].
These conditions share a spectrum of externalization asso-
ciated with personality dimensions named “disinhibition”
and inversely, “retraction” [31–33]. The challenging and op-
positional problems as well as the attention and hyperactiv-
ity problems are common and potentially harmful [31–33].
They frequently occur as comorbidities and share some
common etiological factors. The dopaminergic system in-
fluences and regulates diverse neuronal and physiological
activities such as the sleep/wake cycle, mechanisms of re-
ward and reinforcement, and motivation and learning, be-
sides modulating voluntary movement control [1, 4, 34,
35].. According to Hirvonen et al. (2009), the C/C genotype
is associated with low striatal DRD2 availability (C/C <C/T
<TT) [34]. Nevertheless, the authors, in a study of positron
emission tomography (PET), found that the C/C genotype
was associated with high extrastriatal DRD2 binding poten-
tial throughout the cortex and the thalamus (C/C >C/T >
T/T) [34]. The authors hypothesized that the putative
region-specific features of this SNP could potentially be ex-
plained by differential effects of endogenous dopamine on
receptor binding, regulation of receptor gene and protein
expression or epigenesis, or combination of these factors
together with tracer-specific differences [34].
In this study, the presence of the T allele (C/T and T/T)
was significantly associated with clinical attention and
hyperactivity problems. Deregulation of the reward system
has been proposed as a theoretical model contributing to
attention deficit hyperactivity disorder, in which failure in
the phasic liberation control of dopamine in the striate
would result in injury of the cortico-striatal duct,
Table 4 Presence or absence of the T allele of the rs6277 polymorphism of the DRD2 gene, according to sex and ethnicitya, and
logistic regression analyses
Presence of the T allele (C/T and T/
T)
Absence of the T allele (C/C) p-value χ2
Sex
Female 7 (35%) 13 (65%) 0.140 2.173
Male 35 (53.8%) 30 (46.2%)
Ethnicity
African 0 8 (100%) b b
Bi-racial (African and
Caucasian)
8 (53.3%) 7 (46.7%)
Caucasian 34 (55.7%) 27 (44.3%)
Asiana 0 1 (100%)
CBCL 6/18 cluster of symptoms Univariate analysis Final multivariate stepwise analysis
Odds Ratio 95% Confidence
Interval
p-
value
Odds
Ratio
95% Confidence
Interval
p-
value
Challenging and oppositional problems (without X with alteration)
Sex
Female/Male 0.56 0.2–1.57 0.267 – – –
Ethnicity
Caucasian/African 1.46 0.33–6.56 0.619 – – –
Caucasian/Bi-racial 2.83 0.82–9.76 0.099 – – –
Presence of the T allele of the rs6277 SNP of the DRD2 gene
No/Yes 2.78 1.15–6.71 0.023 2.78 1.15–6.71 0.023
Attention problems and hyperactivity (few X substantial alterations)
Sex
Female/Male 0.66 0.23–1.92 0.444 – – –
Ethnicity
Caucasian/African 0.34 0.04–2.88 0.320 – – –
Caucasian/Bi-racial 0.96 0.27–3.37 0.945 – – –
Presence of the T allele of the rs6277 SNP of the DRD2 gene
No/Yes 2.69 1.001–7.24 0.050 2.69 1.001–7.24 0.050
aAs there was only one child with Asian ethnicity in the study, this category could not be included in the logistic regression models”; “bDegrees of freedom (df) =
3; χ2 test could not be performed as there were not the minimum number of observations in each cell
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influencing the connection between the cingulate anterior
and parietal cortices with the caudate nucleus [36, 37]. Ac-
cording to Dichter et al., dopaminergic function reduction
can be implicated with problems in learning and poor be-
havioral control, but has a reduced influence on rewards
related to the behavior [36].
Oppositional defiant disorder involves the violation of
others’ rights and of the social rules, and is character-
ized by recurrent patterns of defiant behavior against
authority figures, aggressiveness, and violence; it is fre-
quently associated with attention deficit hyperactivity
disorder and other kinds of impulsive behaviors [33, 36,
38, 39]. Dopaminergic polymorphisms have been asso-
ciated with a variety of negative adaptive and antisocial
phenotypes [33, 36]. It has also been suggested that a
disability in impulse control is related to a higher ten-
dency toward violence and aggressiveness [33]. The
hypo-reactivity of the orbitofrontal cortex and the re-
duction of dopaminergic function are related to hypo-
sensitivity of the reward system, favoring transgressor
behaviors, delinquency, and the abuse of psychoactive
substances [39].
A limitation of the present study was the fact that all
of the patients were under psychiatric pharmacological
treatment during the CBCL assessment. In addition, the
parents’ and caregivers’ evaluations regarding the chil-
dren’s or adolescents’ behaviors tended to focus more on
recent problems. The prescription of psychiatric medica-
tions as an attempt to decrease externalizing behavioral
symptoms can have a positive effect on previously prob-
lematic behaviors, and may have influenced the percep-
tion in a minority of cases at the time of the CBCL
assessment. Nevertheless, the scores of recorded behav-
iors were high, suggesting that the symptoms were still
relevant by the time of the interviews, even with medica-
tion use. Another limitation is the small number of par-
ticipants, which prevents the generalization of the
findings. Although preliminary, the findings of this study
suggest there may be a potential association of the T al-
lele of the polymorphism c.957C > T SNP with external-
ized behavioral conditions. Further studies, with a more
representative sample, would also include individuals
with the G/G genotype of the rs1799978 polymorphism
of the DRD2 gene. This would allow more refined tests
for different groups of individuals, including compari-
sons between those with more than one of the SNPs
possibly associated with externalized behavior problems.
The design of this study did not allow to evaluate the
effect of the medication on the genotype. The associa-
tions found may reflect more treatment response rather
than endogenous behavior. Further studies with other
designs, including the use of animal models, might aim
at exploring the influence of psychopharmacologic treat-
ment on the genotype and on the behavior.
Conclusions
The association of the T allele of the polymorphism c.
957C > T (rs6277) with disruptive/aggressive symptoms,
and problems of behavior, oppositional defiance, and at-
tention/hyperactivity suggest that DRD2 gene expression
changes can help with the identification of genetically
associated behavioral and mental phenotypes. New stud-
ies analyzing the possible longitudinal association be-
tween these polymorphisms and the symptoms of more
common occurrence in adults (manic psychotic, depres-
sive symptoms) are encouraged to evaluate these rela-
tionships in more detail. In particular, more in-depth
study of the SNPs are required for applications in not
only improving diagnoses but also for preventive medi-
cine. A broader view of the field of externalized behav-
ioral conditions with respect to personalized medicine
taking into account different genetic susceptibilities may
facilitate the development of new drugs, as well as pro-
vide new ways of prescribing existing drugs, in a genetic-
ally oriented way according to the needs of each patient.
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